Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent
This article is from
The Cancer Letter
archive.
Vol. 39 No. 25 | June 21, 2013
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
L-PAM Benefit To Post-Menopausal Patients Challenged
October 29, 1976
TCL Archive
Leukemia & Lymphoma Society offers translational research grants.
October 24, 2003
TCL Archive
Obituary: Carl Baker, Former NCI Director
March 13, 2009
TCL Archive
13th Congress Advance Program Announcement Now Available
May 1, 1981
TCL Archive
NCI Programs: Institute Seeks White Papers On Technology
September 11, 1998
TCL Archive
HHS Carcinogen Guidelines For Labs Could Apply To Other
May 30, 1980
